Instadose Pharma Corp. (INSD)

USD 0.0

(0.0%)

Long Term Debt Summary of Instadose Pharma Corp.

  • Instadose Pharma Corp.'s latest annual long term debt in 2023 was - USD , down 0.0% from previous year.
  • Instadose Pharma Corp.'s latest quarterly long term debt in 2024 Q1 was - USD , down 0.0% from previous quarter.
  • Instadose Pharma Corp. reported annual long term debt of - USD in 2022, down 0.0% from previous year.
  • Instadose Pharma Corp. reported annual long term debt of - USD in 2021, down 0.0% from previous year.
  • Instadose Pharma Corp. reported quarterly long term debt of - USD for 2023 Q4, down 0.0% from previous quarter.
  • Instadose Pharma Corp. reported quarterly long term debt of - USD for 2023 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Instadose Pharma Corp. (2023 - 2017)

Historical Annual Long Term Debt of Instadose Pharma Corp. (2023 - 2017)

Year Long Term Debt Long Term Debt Growth
2023 - USD 0.0%
2022 - USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%

Peer Long Term Debt Comparison of Instadose Pharma Corp.

Name Long Term Debt Long Term Debt Difference
Bright Green Corporation 201.78 Thousand USD 100.0%
BioQuest Corp. - USD NaN%
Clever Leaves Holdings Inc. 720 Thousand USD 100.0%
Eagle Pharmaceuticals, Inc. 56.21 Million USD 100.0%
Guardion Health Sciences, Inc. - USD NaN%
GSRX Industries Inc. - USD NaN%
High Sierra Technologies, Inc. 50 Thousand USD 100.0%